What does Novo Nordisk invest in?
Novo Nordisk invests most often at Series C and Series A (50% of the rounds on record).
Novo Nordisk highlights
- 01
6 rounds on record
- 02
Mostly Series C and Series A: 50% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2010
1 round
- Apr
- 2008
2 rounds
- Sept
- Mar
- 2007
1 round
- Oct
- 2004
1 round
- Sept
- 2003
1 round
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
0 of 2 we have independently watched raise
Get started todaystock watch
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
XencorListed$70MDec 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
CalibriumUndisclosedAug 2015
MB2UndisclosedAug 2015
Xellia Pharmaceuticals$700MMay 2013
Aldaph SpAUndisclosedOct 2003